2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

[HTML][HTML] Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis

M Grymonprez, S Steurbaut, TL De Backer… - Frontiers in …, 2020 - frontiersin.org
Background and Objective Atrial fibrillation (AF), the most common cardiac arrhythmia,
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …

[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020

МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter

MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

[HTML][HTML] Atrial fibrillation in older people: concepts and controversies

Z Zathar, A Karunatilleke, AM Fawzy, GYH Lip - Frontiers in medicine, 2019 - frontiersin.org
Atrial fibrillation (AF) is the commonest cardiac rhythm abnormality and has a significant
disease burden. Amongst its devastating complications is stroke, the risk of which increases …

Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 …

A Silverio, M Di Maio, C Prota… - European Heart …, 2021 - academic.oup.com
Aims The aim of the present meta-analysis was to evaluate the efficacy and safety of non-
vitamin K oral antagonists (NOACs) vs. vitamin K antagonists (VKAs) in elderly patients with …

Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients

S Deitelzweig, A Keshishian, X Li… - Journal of the …, 2019 - Wiley Online Library
OBJECTIVES Older adult patients are underrepresented in clinical trials comparing non–
vitamin K antagonist oral anticoagulants (NOACs) and warfarin. This subgroup analysis of …

[HTML][HTML] Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists for people aged 75 years and over with atrial fibrillation: a systematic review …

A Mitchell, MC Watson, T Welsh… - Journal of clinical medicine, 2019 - mdpi.com
Older people, are underrepresented in randomised controlled trials of direct oral
anticoagulants (DOACs) for stroke prevention in atrial fibrillation (AF). The aim of this study …

Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis

CG Boer, I Szilagyi, NL Nguyen, T Neogi… - Annals of the …, 2021 - ard.bmj.com
Objectives Vitamin K is hypothesised to play a role in osteoarthritis (OA) pathogenesis
through effects on vitamin K-dependent bone and cartilage proteins, and therefore may …

[HTML][HTML] Direct oral anticoagulants versus warfarin in octogenarians with nonvalvular atrial fibrillation: a systematic review and meta-analysis

C Bonanad, S Garcia-Blas, J Torres Llergo… - Journal of clinical …, 2021 - mdpi.com
Direct oral anticoagulants (DOACs) have been demonstrated to be more effective and safer
than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial …